Nabriva Therapeutics plc NBRV
$ 1.42
0.0%
Quarterly report 2023-Q1
added 05-22-2023
Country |
Irlanda |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Theodore Schroeder |
Employees in the company |
162 |
Shares |
2.68 M |
Market Cap[1] |
$ 4.55 M |
EBITDA (LTM) |
$ -41.5 M |
P/E (LTM) |
-0.1 |
P/S (LTM) |
0.16 |
EPS (LTM) |
-17.23 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.